PALOMA-2: Primary results from a phase III trial of palbociclib (P) with letrozole (L) compared with letrozole alone in postmenopausal women with ER+/HER2– advanced breast cancer (ABC)

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 34; no. 15_suppl; p. 507
Main Authors Finn, Richard S., Martin, Miguel, Rugo, Hope S., Jones, Stephen E., Im, Seock-Ah, Gelmon, Karen A., Harbeck, Nadia, Lipatov, Oleg N., Walshe, Janice Maria, Moulder, Stacy L., Gauthier, Eric Roland, Lu, Dongrui (Ray), Randolph, Sophia, Diéras, Véronique, Slamon, Dennis J.
Format Journal Article
LanguageEnglish
Published 20.05.2016
Online AccessGet full text

Cover

Loading…
Abstract Abstract only
AbstractList Abstract only
Author Walshe, Janice Maria
Moulder, Stacy L.
Randolph, Sophia
Gelmon, Karen A.
Rugo, Hope S.
Slamon, Dennis J.
Finn, Richard S.
Harbeck, Nadia
Martin, Miguel
Jones, Stephen E.
Gauthier, Eric Roland
Lu, Dongrui (Ray)
Lipatov, Oleg N.
Diéras, Véronique
Im, Seock-Ah
Author_xml – sequence: 1
  givenname: Richard S.
  surname: Finn
  fullname: Finn, Richard S.
  organization: David Geffen School of Medicine, Santa Monica, CA
– sequence: 2
  givenname: Miguel
  surname: Martin
  fullname: Martin, Miguel
  organization: Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain
– sequence: 3
  givenname: Hope S.
  surname: Rugo
  fullname: Rugo, Hope S.
  organization: University of California, San Francisco, San Francisco, CA
– sequence: 4
  givenname: Stephen E.
  surname: Jones
  fullname: Jones, Stephen E.
  organization: US Oncology Research, and The Woodlands, The Woodlands, TX
– sequence: 5
  givenname: Seock-Ah
  surname: Im
  fullname: Im, Seock-Ah
  organization: Seoul National University Hospital, Seoul, South Korea
– sequence: 6
  givenname: Karen A.
  surname: Gelmon
  fullname: Gelmon, Karen A.
  organization: BC Cancer Agency, Vancouver, BC, Canada
– sequence: 7
  givenname: Nadia
  surname: Harbeck
  fullname: Harbeck, Nadia
  organization: Brustzentrum der Universität München (LMU), Munich, Germany
– sequence: 8
  givenname: Oleg N.
  surname: Lipatov
  fullname: Lipatov, Oleg N.
  organization: State Budget Medical Institution, Republican Clinical Oncology, Ufa, Russian Federation
– sequence: 9
  givenname: Janice Maria
  surname: Walshe
  fullname: Walshe, Janice Maria
  organization: Adelaide and Meath Hospital, Dublin, Ireland
– sequence: 10
  givenname: Stacy L.
  surname: Moulder
  fullname: Moulder, Stacy L.
  organization: The University of Texas MD Anderson Cancer Center, Houston, TX
– sequence: 11
  givenname: Eric Roland
  surname: Gauthier
  fullname: Gauthier, Eric Roland
  organization: Pfizer Inc, La Jolla, CA
– sequence: 12
  givenname: Dongrui (Ray)
  surname: Lu
  fullname: Lu, Dongrui (Ray)
  organization: Pfizer Inc, La Jolla, CA
– sequence: 13
  givenname: Sophia
  surname: Randolph
  fullname: Randolph, Sophia
  organization: Pfizer Inc, San Diego, CA
– sequence: 14
  givenname: Véronique
  surname: Diéras
  fullname: Diéras, Véronique
  organization: Institut Curie, Paris, France
– sequence: 15
  givenname: Dennis J.
  surname: Slamon
  fullname: Slamon, Dennis J.
  organization: University of California, Los Angeles, Los Angeles, CA
BookMark eNpdkdFKwzAUhoNMcJu-w7nckHZJ07TVuzmmm0w2hoJ3IUlTVsmaknQOvfIdfBsfxyexY3rj1Tk__-Hn8H891KlspRECgkMSYTy6nyzDCJMkpHFIGPe7ujYhw-kJ6hIWpUGaMtZBXZzSKCAZfT5DPe9fMCZxRlkXfa3Gi-XDOIiuYeXKrXBv4LTfmcZD4ewWBNQb4TXM53NoXCkM2AJqYaRVpTKlhMFqCPuy2YDRjbPv1mgYLIag7LYWTuf_PWHa96GsoLa-2erK1mLn29S9bcXxeLq-HM2m6-j74xNE_ioq1cZIp4VvQB2Ug8H4ZjI8R6eFMF5f_M4-erqdPk5mwWJ5N5-MF4EiOE4DIkmSk1xgTbJMFjTXuRZR210uJWappIWULElJu8SCZSq_YhSrSMo4TpJYMtpH2TFXOeu90wWvj01xgvmBAW8Z8AMDTmP-x4C3DOgP2kmA_A
CitedBy_id crossref_primary_10_18632_oncotarget_17262
crossref_primary_10_1007_s41975_017_0023_z
crossref_primary_10_1158_1078_0432_CCR_18_1968
crossref_primary_10_1016_j_ctrv_2016_08_008
crossref_primary_10_1016_S0140_6736_16_31891_8
crossref_primary_10_1016_j_pharmthera_2017_02_008
crossref_primary_10_1200_JCO_2016_71_5292
crossref_primary_10_1530_ERC_16_0404
crossref_primary_10_1530_ERC_18_0021
crossref_primary_10_4137_CMT_S18492
crossref_primary_10_1136_esmoopen_2016_000093
crossref_primary_10_1158_2159_8290_CD_16_0440
crossref_primary_10_1080_14737140_2020_1834385
crossref_primary_10_1530_ERC_16_0121
crossref_primary_10_1056_NEJMoa1609709
crossref_primary_10_1634_theoncologist_2015_0464
crossref_primary_10_1007_s12609_017_0231_1
crossref_primary_10_1136_bmjopen_2021_055821
crossref_primary_10_3322_caac_21777
crossref_primary_10_2217_fon_2017_0088
crossref_primary_10_1080_03007995_2017_1325730
crossref_primary_10_1158_1078_0432_CCR_23_1796
crossref_primary_10_1007_s12282_017_0818_4
crossref_primary_10_1007_s10549_017_4658_x
crossref_primary_10_1158_1078_0432_CCR_16_0591
crossref_primary_10_1007_s10549_020_06082_7
crossref_primary_10_1007_s11523_017_0492_7
crossref_primary_10_1080_14656566_2016_1269748
crossref_primary_10_1016_j_breast_2021_02_015
crossref_primary_10_20960_revcancer_00018
crossref_primary_10_1080_21556660_2020_1857103
crossref_primary_10_1016_j_actpha_2016_11_011
crossref_primary_10_1177_2042098617722516
crossref_primary_10_1002_cam4_4055
crossref_primary_10_3892_mco_2019_1955
crossref_primary_10_1016_j_bbcan_2018_05_004
crossref_primary_10_1016_j_breast_2016_10_001
crossref_primary_10_1016_j_ctrv_2016_09_011
crossref_primary_10_1080_14656566_2018_1504922
crossref_primary_10_1634_theoncologist_2017_0142
crossref_primary_10_1007_s10555_016_9636_y
crossref_primary_10_1158_0008_5472_CAN_18_1235
crossref_primary_10_21294_1814_4861_2018_17_3_11_19
crossref_primary_10_3390_cancers12082252
crossref_primary_10_1016_j_cpcardiol_2018_10_003
crossref_primary_10_1530_ERC_16_0427
crossref_primary_10_1007_s10549_016_3979_5
crossref_primary_10_1002_cncr_33918
crossref_primary_10_1016_S0140_6736_16_32419_9
crossref_primary_10_1007_s41974_017_0022_8
crossref_primary_10_1016_j_jdcr_2017_12_015
crossref_primary_10_1038_ncomms15916
crossref_primary_10_3390_app11052089
crossref_primary_10_1007_s10549_022_06755_5
crossref_primary_10_1177_1758834016677961
crossref_primary_10_36290_xon_2017_032
crossref_primary_10_3390_cancers15010316
crossref_primary_10_1007_s12254_016_0300_6
crossref_primary_10_1200_JCO_2016_69_0032
crossref_primary_10_3390_cells9030668
crossref_primary_10_3390_cells8040321
crossref_primary_10_1080_03007995_2018_1503484
crossref_primary_10_12688_f1000research_17542_1
crossref_primary_10_1177_17588359241239293
crossref_primary_10_3390_cancers15051416
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1200/JCO.2016.34.15_suppl.507
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1527-7755
EndPage 507
ExternalDocumentID 10_1200_JCO_2016_34_15_suppl_507
GroupedDBID ---
.55
0R~
18M
2WC
34G
39C
4.4
53G
5GY
5RE
8F7
AAQOH
AARDX
AAWTL
AAYEP
AAYOK
AAYXX
ABJNI
ABOCM
ACGFO
ACGFS
ACGUR
ADBBV
AEGXH
AENEX
AIAGR
ALMA_UNASSIGNED_HOLDINGS
AWKKM
BAWUL
C45
CITATION
CS3
DIK
EBS
EJD
F5P
F9R
FBNNL
FD8
GX1
H13
HZ~
IH2
K-O
KQ8
L7B
LSO
MJL
N9A
O9-
OK1
OVD
OWW
P2P
QTD
R1G
RHI
RLZ
RUC
SJN
SV3
TEORI
TR2
TWZ
UDS
VVN
WH7
X7M
YCJ
YFH
YQY
ID FETCH-LOGICAL-c1047-1b16d1da0e188bf3dedea2120dbb057b3fbb5671b3f4a58cd9530c2bb44664b53
ISSN 0732-183X
IngestDate Fri Aug 23 02:35:57 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 15_suppl
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1047-1b16d1da0e188bf3dedea2120dbb057b3fbb5671b3f4a58cd9530c2bb44664b53
PageCount 1
ParticipantIDs crossref_primary_10_1200_JCO_2016_34_15_suppl_507
PublicationCentury 2000
PublicationDate 2016-05-20
PublicationDateYYYYMMDD 2016-05-20
PublicationDate_xml – month: 05
  year: 2016
  text: 2016-05-20
  day: 20
PublicationDecade 2010
PublicationTitle Journal of clinical oncology
PublicationYear 2016
SSID ssj0014835
Score 2.2315674
Snippet Abstract only
SourceID crossref
SourceType Aggregation Database
StartPage 507
Title PALOMA-2: Primary results from a phase III trial of palbociclib (P) with letrozole (L) compared with letrozole alone in postmenopausal women with ER+/HER2– advanced breast cancer (ABC)
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtNAEF6VIiEuCAqI8qcRQlWiNK69azsutzRKSVBDrJBKuVle2ymRojhq4kN74h14Gx6HJ2HGu3acFgT0Ejm2M7Izn3dnxt9-w9j7MJ6arSi2m5YXmpigJPhIRV7U5DxKhBk7XOZC2oPPbu_c_jRxJjv33lVYS9laGtH1b9eV3MWruA_9Sqtk_8OzpVHcgdvoX_xED-PnP_nYb58NB-0mp7Te17IRmD5n8_VKrRsJG8uvOE01-v1-Q_XnIIJzOJfokggzZYovfSoM5OVYdOFlek10Q-rzQbu3Geqb4-E8VWojy3RFNHXMvLMVWs_1HNTJxLA4wVvrdUe8YFSIDeVAEhl-TZyziMQsuNc-6RRViduxcrl-M11EW-8BTmeLqj5A44uxKbEX-giD2UWWlESSUXaRV4d76TKpnF72LNC0t0bXqBZELJfe5XOzMm62BEfo5W2GcYrT4zpvYSKhFIGLgV9XUTXAnWBFfVQrg7mj-vHquEB_uzXlcNVNuzMknqBrCNsoTBmlgarK943Zt-REUjbG6dViZxiQpUDYQWEpcEgw4T7HwZRG8Y-TksaE2axqIlvctGaroaWjP11TJQSrxFLjx-yRdiy0FaKfsJ1kscceDDTNY48d-EpQ_eoQxpv1gatDOAB_I7V-9ZT9KJ6AD6DxDxr_QPiHEHL8A-IfcvxDOoUK_qHm14HgCiW2oXZWhwL3N4_luIfZArZxDznu1cndUeOIMP_z23co0A4K7aDQDjXEev0ZOz_tjju9pu5G0oxyORNLWm5sxaGZWJ4npyJO4iTEwM-MpcSkR4qplI7bsnDDDh0vio8dYUZcSmJM2NIRz9nuAi_yBQPPpbhRephuCFvEYSglF1PvODZtIS1u7TOrcFCwVP9e8Dd4vLzDb16xh5sH6DXbXV9myRuMsdfybQ6yX8y1ziU
link.rule.ids 315,783,787,27936,27937
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PALOMA-2%3A+Primary+results+from+a+phase+III+trial+of+palbociclib+%28P%29+with+letrozole+%28L%29+compared+with+letrozole+alone+in+postmenopausal+women+with+ER%2B%2FHER2%E2%80%93+advanced+breast+cancer+%28ABC%29&rft.jtitle=Journal+of+clinical+oncology&rft.au=Finn%2C+Richard+S.&rft.au=Martin%2C+Miguel&rft.au=Rugo%2C+Hope+S.&rft.au=Jones%2C+Stephen+E.&rft.date=2016-05-20&rft.issn=0732-183X&rft.eissn=1527-7755&rft.volume=34&rft.issue=15_suppl&rft.spage=507&rft.epage=507&rft_id=info:doi/10.1200%2FJCO.2016.34.15_suppl.507&rft.externalDBID=n%2Fa&rft.externalDocID=10_1200_JCO_2016_34_15_suppl_507
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0732-183X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0732-183X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0732-183X&client=summon